Real world evidence insights

coming soon in Q4'2023 to transform Data-Driven decisions
Together with Retina Consultants of America, we are collaborating to build the most comprehensive Real World Evidence (RWE) insights in Ophthalmology. We will combine clinical and imaging data with AI-driven biomarker and endpoint measures to provide an in-depth understanding to retinal diseases such as Age-related Macular Degeneration (AMD) - including intermediate AMD (iAMD), Geographic Atrophy (GA), neovascular AMD (nAMD) - as well as insights into Diabetic Macular Edema (DME), Diabetic Retinopathy (DR) and other retinal disease.

Benefits of accessing Real World Evidence Insights

Research and Development

  • Improve clinical study design
  • Optimize therapeutic target selection
  • Accelerate time to market

Medical and Commercial

  • Enable pharmacovigilance strategies
  • Improve targeting of commercial activities
  • Generate evidence of economis value

Novel Opportunities

  • Opportunities to develop precision-based medicine or diagnostics

Find out more about collaboration with RCA

Retina Consultants of America

RetinAI Medical AG and Retina Consultants of America (RCA)
forge a strategic partnership to revolutionize Ophthalmology data.
Leveraging RetinAI's advanced AI technologies and RCA's
expansive clinic network, this alliance is set to develop
the largest Real World Evidence (RWE)
U.S.-based database in the field.
Learn more >

Interested in learning more?

Request a demo of our AI-based technologies today by filling the form, we will give you an intro to the perfect solution that fits your business or stay informed about our launch of RWE insights... Or both!


RetinAI Discovery is a CE-marked medical device according to the Medical Devices Regulation (EU) 2017/745
and the AI models are CE-marked devices according to Medical Devices Directive 93/42/EEC
RetinAI Discovery® is a 510(k) FDA Cleared medical device in US.
RetinAI Discovery® and Retinai® are both trademarks of RetinAI Medical AG.

Discovery and AI Models are CE-Marked medical devices since April 2020 & December 2020 respectively.